MB Hema consult Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 9,310 |
| - |
| -361 |
| -361 |
| - |
| 100.00 |
| -3.88 |
| 17,648 |
| 783 |
| 0 |
| 18,431 |
| 1.90 |
| 0.04 |
| - |
| - |
| -3.88 |
| -361 |
| 2024 |
|---|
| 6,128 |
| - |
| -24 |
| -24 |
| - |
| 100.00 |
| -0.39 |
| 17,624 |
| 12 |
| 0 |
| 17,636 |
| 2.88 |
| 0.00 |
| - |
| - |
| -0.39 |
| -24 |
| 2025 |
|---|
| 7,075 |
| - |
| -8 |
| -8 |
| - |
| 100.00 |
| -0.11 |
| 17,616 |
| 725 |
| 0 |
| 18,341 |
| 2.49 |
| 0.04 |
| - |
| - |
| -0.11 |
| -8 |
| 2025 |
|---|
| 7,075 |
| - |
| -8 |
| -8 |
| - |
| 100.00 |
| -0.11 |
| 17,616 |
| 725 |
| 0 |
| 18,341 |
| 2.49 |
| 0.04 |
| - |
| - |
| -0.11 |
| -8 |
Turnover (€)
2025
Turnover (€)
7,075 €15 % *
Sales per employee (€)
-Profit before tax (€)
-8 €67 % *
Net Profit (€)
-8 €67 % *
Profit per employee (€)
-Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
-0.11 %71.79 % *
Equity (€)
17,616 €0 % *
Amounts Payable And Liabilities (€)
725 €5,942 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
18,341 €4 % *
Working capital requirement
2.49 -13.54 % *
Debt-to-equity ratio
0.04 - *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-0.11 %71.79 % *
EBIT (€)
-8 €67 % *
